Skip to main content

Want a detailed portfolio tracker?

Nuvectis Pharma (NVCT) P/E (2022 - 2026)

Nuvectis Pharma (NVCT) P/E from Feb 4, 2022 to Jul 21, 2026. The TTM Nuvectis Pharma (NVCT) P/E is -17.85. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nuvectis Pharma (NVCT)

YearP/EChange
2026-17.85+152.11%
2025-7.08+31.23%
2024-5.40-10.24%
2023-6.01+13.42%
2022-5.30N/A

Comparison Nuvectis Pharma (NVCT) P/E with competitors

Nuvectis Pharma (NVCT) P/E is -17.85.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.42%
FGENFibroGen Inc0.24-101.34%
CHRSCoherus Biosciences Inc0.85-104.75%
FBIOFortress Biotech Inc0.95-105.32%
ORMPOramed Pharmaceuticals Inc1.50-108.42%
AGENAgenus Inc3.01-116.86%
INVAInnoviva Inc3.15-117.67%
VXRTVaxart Inc3.55-119.88%
CRMDCorMedix Inc3.63-120.33%
CVACCureVac N.V.4.45-124.90%
GLPGGalapagos NV4.86-127.22%
SRPTSarepta Therapeutics Inc4.88-127.35%
ABEOAbeona Therapeutics Inc5.39-130.18%
ABUSArbutus Biopharma Corp5.60-131.34%
ZVRAZevra Therapeutics Inc5.89-132.98%
SPROSpero Therapeutics Inc6.23-134.89%
CGENCompugen Ltd6.31-135.37%
RIGLRigel Pharmaceuticals6.87-138.49%
SLXNSilexion Therapeutics Corp7.30-140.87%
OMEROmeros Corporation9.26-151.86%
AUPHAurinia Pharmaceuticals Inc9.58-153.69%
PLXProtalix BioTherapeutics Inc10.89-161.01%
ACADAcadia Pharmaceuticals Inc11.73-165.70%
TBPHTheravance Biopharma Inc12.26-168.69%
ADMAAdma Biologics Inc12.42-169.56%
HRMYHarmony Biosciences Holdings Inc13.82-177.42%
SABSSAB Biotherapeutics Inc14.14-179.19%
NAGENiagen Bioscience Inc14.82-183.01%
INCYIncyte Corp15.82-188.63%
REGNRegeneron Pharmaceuticals Inc15.86-188.82%
PBYIPuma Biotechnology Inc17.32-197.00%
CPRXCatalyst Pharmaceuticals Inc17.44-197.69%
EXELExelixis Inc17.54-198.24%
TGTXTG Therapeutics Inc18.97-206.24%
MDXGMimedx Group Inc20.55-215.13%
XOMAXOMA Royalty Corp22.87-228.14%
ARGXArgen X SE24.30-236.11%
CTMXCytomX Therapeutics Inc24.82-239.04%
XOMAOXOMA Royalty Corp25.34-241.98%
HALOHalozyme Therapeutics Inc25.62-243.54%
XOMAPXOMA Royalty Corp25.67-243.80%
VRTXVertex Pharmaceuticals Inc27.99-256.82%
RPRXRoyalty Pharma plc - Class A28.69-260.70%
SLNOSoleno Therapeutics Inc29.02-262.54%
ASNDAscendis Pharma A/S30.09-268.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-312.38%
APLSApellis Pharmaceuticals Inc39.02-318.59%
BMRNBiomarin Pharmaceutical Inc42.21-336.46%
KRYSKrystal Biotech Inc45.34-354.00%
ONCBeiGene Ltd69.54-489.55%
PHARPharming Group N.V.75.03-520.28%
TECHBio-Techne Corp101.96-671.15%
VCELVericel Corp109.92-715.76%
ALNYAlnylam Pharmaceuticals Inc117.96-760.82%
GMABGenmab140.29-885.88%
TLXTelix Pharmaceuticals Ltd162.15-1008.35%
CORTCorcept Therapeutics Inc212.86-1292.38%